Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 2/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PER2 | O15055 | 1/20 | 0.31 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.31 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.31 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24374246 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1HDAC4PTGES | |
| SCHEMBL24374020 | 0.98 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4PTGES | |
| SCHEMBL24374285 | 0.98 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4PTGES | |
| SCHEMBL24374244 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1HDAC4PTGES | |
| SCHEMBL24946733 | 0.96 | KDM4E (0.39) | KDM4EATML3MBTL1F2F10 | |
| SCHEMBL24947317 | 0.96 | KDM4E (0.33) | KDM4EATML3MBTL1HDAC4PTGES | |
| SCHEMBL26710275 | 0.95 | KDM4E (0.35) | KDM4EATML3MBTL1HDAC4PTGES | |
| SCHEMBL24374120 | 0.95 | KDM4E (0.35) | KDM4EATML3MBTL1HDAC4PTGES | |
| SCHEMBL26710277 | 0.95 | KDM4E (0.35) | KDM4EATML3MBTL1HDAC4PTGES | |
| SCHEMBL19508302 | 0.95 | ESR1 (0.34) | KDM4EATML3MBTL1HDAC4PTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023002447-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-26 | — | — | WO | disclosed |
| WO-2023003403-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-26 | — | — | WO | disclosed |
| WO-2021129337-A1 | ORGANIC COMPOUND AND ORGANIC ELECTRONIC DEVICE | 广州华睿光电材料有限公司 | 2021-07-01 | — | — | WO | disclosed |
| US-10026905-B2 | Compound, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-07-17 | — | — | US | disclosed |
| US-10026905-B2 | Compound, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-07-17 | — | — | US | disclosed |
| US-20140374722-A1 | COMPOUND, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2014-12-25 | — | — | US | disclosed |
| US-20140374722-A1 | COMPOUND, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2014-12-25 | — | — | US | disclosed |
| WO-2013109027-A1 | COMPOUND, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF | 덕산하이메탈(주) (KR) | 2013-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10026905-B2 | Compound, organic electric element using the same, and an electronic device thereof | ORAI2, TMEM109, EML4 | KDM4E 1695/4885ATM 4083/4885L3MBTL1 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.